 | • レポートコード：MRC-IM30332 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年22億ドルであった世界の分岐病変市場規模が2027年には30億ドルに達し、予測期間中、年平均5.5％成長すると予測しています。本調査レポートでは、分岐病変の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（ワンステント、ツーステント）分析、用途別（冠血管、末梢血管）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。また、こちらの調査レポートに掲載されている企業情報には、Boston Scientific Corporation, Cardinal Health, Medtronic plc, Spectranetics (Koninklijke Philips N.V.)などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の分岐病変市場規模：種類別 - ワンステントの市場規模 - ツーステントの市場規模 ・世界の分岐病変市場規模：用途別 - 冠血管における市場規模 - 末梢血管における市場規模 ・世界の分岐病変市場規模：地域別 - 北米の分岐病変市場規模 - アジアの分岐病変市場規模 - 欧州の分岐病変市場規模 - 中南米の分岐病変市場規模 - 中東・アフリカの分岐病変市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global bifurcation lesions market size reached US$ 2.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2027, exhibiting a growth rate (CAGR) of 5.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
A bifurcation lesion refers to the narrowing of the coronary artery adjacent to the origin of a significant side branch (SB). It is prone to develop atherosclerotic plaque due to turbulent blood flow and high shear stress. It is treated using techniques like analysis, procedure duration, X-ray exposure, and long-term follow-up. Moreover, three-dimensional (3D) angiography and multi-slice computed tomography are utilized for measuring the bifurcation angles. With the advances in devices, imaging, adjunctive pharmacotherapy, and vascular access, the management of complex cases of bifurcation lesions is becoming possible worldwide.
Bifurcation Lesions Market Trends:
A significant rise in the occurrence of coronary artery disease (CAD) is increasing the risk of developing bifurcation lesions. This represents one of the key factors bolstering the market growth. Besides this, the approval of innovative devices, increasing insurance coverage, and improving imaging modalities are also strengthening the market growth. Moreover, the rising geriatric population, which is more likely to develop medical ailments, along with supportive initiatives undertaken by governments of various countries for reimbursement, is supporting the market growth. The increasing medical tourism, the escalating demand for minimally invasive (MI) procedures and the improving healthcare infrastructure are some of the other factors contributing to the growth of the market. Apart from this, the ongoing research on novel treatment techniques is driving the market. For instance, researchers are studying the effectiveness of the Szabo 2-stent technique for complex bifurcations lesions with high compromise risk or fatal consequences of SB occlusion. Furthermore, a wide range of clinical trials on stents and balloons, in confluence with the increasing number of skilled healthcare professionals, is anticipated to decrease risks associated with bifurcation lesions treatment and influence the market positively.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global bifurcation lesions market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on types and application.
Breakup by Types:
One-Stent
Two-Stent
Breakup by Application:
Coronary Vascular
Peripheral Vascular
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, Cardinal Health, Medtronic plc, Spectranetics (Koninklijke Philips N.V.) and Terumo Corporation.
Key Questions Answered in This Report
1. What was the size of the global bifurcation lesions market in 2021?
2. What is the expected growth rate of the global bifurcation lesions market during 2022-2027?
3. What has been the impact of COVID-19 on the global bifurcation lesions market?
4. What are the key factors driving the global bifurcation lesions market?
5. What is the breakup of the global bifurcation lesions market based on the application?
6. What are the key regions in the global bifurcation lesions market?
7. Who are the key players/companies in the global bifurcation lesions market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Bifurcation Lesions Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Types
6.1 One-Stent
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Two-Stent
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Application
7.1 Coronary Vascular
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Peripheral Vascular
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Boston Scientific Corporation
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Cardinal Health
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Medtronic plc
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 Spectranetics (Koninklijke Philips N.V.)
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.5 Terumo Corporation
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
Figure 2: Global: Bifurcation Lesions Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Bifurcation Lesions Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Bifurcation Lesions Market: Breakup by Types (in %), 2021
Figure 5: Global: Bifurcation Lesions Market: Breakup by Application (in %), 2021
Figure 6: Global: Bifurcation Lesions Market: Breakup by Region (in %), 2021
Figure 7: Global: Bifurcation Lesions (One-Stent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Bifurcation Lesions (One-Stent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Bifurcation Lesions (Two-Stent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Bifurcation Lesions (Two-Stent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Bifurcation Lesions (Coronary Vascular) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Bifurcation Lesions (Coronary Vascular) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Bifurcation Lesions (Peripheral Vascular) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Bifurcation Lesions (Peripheral Vascular) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: North America: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: North America: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: United States: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: United States: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Canada: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Canada: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Asia-Pacific: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Asia-Pacific: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: China: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: China: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Japan: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Japan: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: India: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: India: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: South Korea: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: South Korea: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Australia: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Australia: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Indonesia: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Indonesia: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Others: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Europe: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Europe: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Germany: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Germany: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: France: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: France: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: United Kingdom: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: United Kingdom: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Italy: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Italy: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Spain: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Spain: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Russia: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Russia: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Others: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Latin America: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Latin America: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Brazil: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Brazil: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Mexico: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Mexico: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Others: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Middle East and Africa: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Middle East and Africa: Bifurcation Lesions Market: Breakup by Country (in %), 2021
Figure 63: Middle East and Africa: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Global: Bifurcation Lesions Industry: SWOT Analysis
Figure 65: Global: Bifurcation Lesions Industry: Value Chain Analysis
Figure 66: Global: Bifurcation Lesions Industry: Porter's Five Forces Analysis
